期刊文献+

结外NK/T细胞淋巴瘤相关性噬血细胞综合征临床分析 被引量:1

Clinical Analysis of Extranodal NK / T-cell Lymphoma Associated Hemophagocytic Syndrome
下载PDF
导出
摘要 目的探讨结外NK/T细胞淋巴瘤(ENTKL)合并噬血细胞综合征(HPS)(ENKTL—LAHS)的临床特征、诊断、治疗及预后。方法分析3例NK/T—LAHS患者的临床资料,并进行文献复习。结果3例ENK-TL—LAHS患者年龄均小于60岁。2例淋巴瘤初诊时具有多项不良预后因素。3例ENKTL—LAHS患者均处于淋巴瘤的治疗和进展阶段。临床表现为持续高热、2~3系血细胞进行性减低、脾肿大、肝功能异常、铁蛋白升高及高TG血症等。发生HPS后病情进展迅速,短期内合并多器官功能不全综合征或弥漫性血管内凝血而死亡。自合并HPS后生存期18—124d。结论ENKTL—LAHS多见于中青年,多发生在ENKTL的进展或复发阶段,其临床特点不典型,早期诊断困难,尚缺乏有效治疗手段,预后差。 Objective To explore the clinical features, diagnosis, treatment and prognosis of extranodal NK/T- cell lymphoma(ENKTL)associated hemophagocytie syndrome(HPS) (ENKTL-LAHS). Methods The clinical data of 3 patients with ENKTL-LAHS were retrospectively analyzed, and the related literature was reviewed. Results All the 3 patients were under 60 years old. Two of them at newly diagnosis had more than two risk factors indicating poor prognosis. All the 3 patients developed HPS at the progression or recurrence of lymphoma, and had the following clinical features : persistent high fever,2-3 hemocyte decrease, splenomegaly, abnormal liver function, increased ser- um ferritin and triglyceride. The disease progressed rapidly after onset of HPS,leading to death in a short period due to multiple organ dysfunction syndrome or disseminated intravaseular coagulation. The survival time of 3 patients after onset of HPS were 18-124 days. Conclusion ENKTL-LAHS appears most frequently at the progression or recur- rence of ENKTL, at the age less than 60 years old. Its clinical features are not typical, and the early diagnosis is difficult. The therapeutic response and prognosis of ENKTL-LAHS are extremely poor.
出处 《肿瘤基础与临床》 2015年第6期520-523,共4页 journal of basic and clinical oncology
基金 国家自然科学基金资助项目(编号:U1404833)
关键词 结外NK/T细胞淋巴瘤 噬血细胞综合征 诊断 治疗 预后 extranoda] NK/T-cell lymphoma hemophagocytie syndrome diagnosis treatment prognosis
  • 相关文献

参考文献18

  • 1Janka GE. Familial and acquired hemophagocyticlymphohistiocytosis[J]. Annu Rev Med,2012,63 :233 -246.
  • 2Takahashi N,Chubachi A,Kume M,et al. A clinical analysis of 52adult patients with hemophagocytic syndrome .. the prognostic signifi-cance of the underlying diseasesf J]. Int J Hematol,2001,74(2):209 -213.
  • 3Han AK, Lee HR,Park BB,et al. Lymphoma-associated hemoph-agocytic syndrome : clinical features and treatment outcome f J ].Ann Hematol, 2007,86 (7) :493 -498.
  • 4王晶石,王昭,吴林,田莉萍,陈晳.淋巴瘤相关性噬血细胞综合征14例临床分析[J].中国实验血液学杂志,2009,17(5):1352-1355. 被引量:28
  • 5张燕,洪小南.结外NK/T细胞淋巴瘤相关嗜血细胞综合征23例回顾性分析[J].中华肿瘤防治杂志,2013,20(21):1672-1675. 被引量:12
  • 6Sabattini E, Bacci F, Sagramoso C, et al. WHO classification oftumours of haematopoietic and lymphoid tissues in 2008: an over-view [J]. Pathologica,2010,102(3) :83 -87.
  • 7Sano H,Kobayashi R,Tanaka J,et al. Risk factor analysis of non-Hodgkin lymphoma-associated haemophagocytic syndromes : a mul-ticentre studyf J]. Br J Haematol,2014,165(6) :786 -792.
  • 8Tong H,Ren Y,Liu H,et al. Clinical characteristics of T-cell lym-phoma associated with hemophagocytic syndrome : comparison of T-cell lymphoma with and without hemophagocytic syndrome [ J ].Leuk Lymphoma ,2008,49 (1) :81 -87.
  • 9Takai K,Nikkuni K,Sanada M,et al. EB virus-associated peripher-al T cell lymphoma presenting with hemophagocytic syndrome andhepatic cell necrosis [ J ]. Rinsho Ketsueki,2003, 44 ( 7 ):.
  • 10Han L,Li L,Wu J,et al. Clinical features and treatment of naturalkiller/T cell lymphoma associated with hemophagocytic syndrome :comparison with other Tcell lymphoma associated with hemophago-cytic syndrome[ J]. LeukLymphoma, 2014,55(9) :2048 -2055.

二级参考文献48

  • 1周立强,孙燕,谭文勇,李陶,王琦路,冯凤仪,王金万,储大同,石远凯,李晔雄,孙云田,吕宁.非霍奇金淋巴瘤1125例临床病理分析[J].癌症进展,2006,4(5):391-397. 被引量:47
  • 2Janka GE. Familial and acquired hemophagocytie lymphohistiocytosis. Eur J Pediatr, 2007; 166:95-109.
  • 3Janka GE, Schneider EM. Modem management of children with haemophagocytic lymphohistiocytosis. Br J Haematol, 2004; 124: 4- 14.
  • 4Henter JI, Home AC, Arico M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer, 2007 ; 48 : 124 - 131.
  • 5Kontopoulou T, Tsaousis G, Vaidakis E, et al. Hemophagoeytic syndrome in association with visceral lcishmaniasis. Am J Med, 2002; 113 : 439 -440.
  • 6Gupta A, Tyrrell P, Valani R, et al. The role of the initial bone marrow aspirate in the diagnosis of hernophagocytic lymphohistiocytosis. Pediatr Blood Cancer, 2008 ; 51 : 402 - 404.
  • 7Janka GE. Familial and acquired hemophagocytic lymphohistiocytosis. Eur J Pediatr, 2007; 166:95 - 109.
  • 8Han AR,Lee HR,Park BB, et al. Lymphoma-associated hemophagocytic syndrome:clinical features and treatment outcome. Ann Hematol, 2007 ; 86 : 493 - 498.
  • 9Henter JI, Home A, Arico M, et al. HLH-2004: Diagnostic and Therapeutic Guidelines for Hemophagocytic Lymphohistioeytosis. Pediatr Blood Cancer, 2007 ; 48 : 124 - 131.
  • 10Bielekova B, Catalfamo M, Reichert-Scrivner S, et al. Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy ( daclizumab ) in multiple sclerosis. Proc Natl Acad Sci USA, 2006; 103:5941 -5946.

共引文献64

同被引文献7

引证文献1

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部